BUSINESS● LOWOct 1 · Oct 1, 2026, 8:54 AM
Teva and Samsung Bioepis partner on up to six biosimilars
Seeking Alpha Tech · global
Teva and Samsung Bioepis have announced a partnership to collaborate on the development of up to six biosimilar products. This alliance represents a strategic move in the pharmaceutical industry to expand their biosimilar portfolios.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowCritical minerals: why development banks are making a comeback in the sectorJeune AfriqueBUSINESS33m agoOccidental Petroleum raised to Buy at Roth as one of better ways to play oil upsideSeeking Alpha Tech